Home Companies Fitch downgrades Jubilant Pharma to "BB-" indicating higher default risk

Fitch downgrades Jubilant Pharma to "BB-" indicating higher default risk

02:17

Rating agency foresees firm's financial leverage worsening as a rise in capex will coincide with lower profitability

from Companies https://ift.tt/fkMc3vT

No comments:

Subscribe to: Post Comments ( Atom )